Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The contraceptive devices market has been experiencing significant growth recently, driven by increasing awareness and advancements in reproductive health. As family planning gains more attention worldwide, the market continues to evolve with new technologies and expanding access, promising steady growth in the coming years. Let’s explore the current market size, key drivers, product segments, emerging trends, leading companies, and regional dynamics shaping this sector.

Steady Growth and Market Size Expectations in the Contraceptive Devices Market

The contraceptive devices market has seen a strong upward trajectory in recent years. It is projected to grow from $13.55 billion in 2025 to $14.4 billion in 2026, marking a compound annual growth rate (CAGR) of 6.3%. This expansion in the past can largely be linked to increased awareness about family planning, government-backed population control initiatives, the rise in unintended pregnancies, wider reproductive health services, and improved availability of over-the-counter contraceptives. Looking ahead, the market is expected to continue robust growth, reaching $18.31 billion by 2030 with a CAGR of 6.2%. Factors contributing to this forecast include a stronger emphasis on reproductive autonomy, rising demand for long-term and easy-to-use contraceptive options, growth in digital health and online pharmacy platforms, greater adoption of male contraceptive methods, and the influence of public and NGO-led sexual health programs. Notable trends during this period involve increased use of long-acting reversible contraceptives, female-controlled options, non-hormonal devices, and expanded access through online and public distribution channels, as well as a focus on dual protection against pregnancy and sexually transmitted infections (STIs).

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

The Rising Impact of Sexually Transmitted Diseases on Market Demand

One of the critical factors driving the contraceptive devices market is the increasing incidence of sexually transmitted diseases (STDs). These infections, primarily spread through sexual contact, affect multiple body systems and can lead to serious health issues. The rise in STDs is attributed to factors such as increased sexual activity, inadequate protection use, limited sexual health education, and barriers to healthcare and testing services. Contraceptive devices, especially condoms, play a crucial role in preventing the transmission of STDs by acting as a protective barrier against infectious fluids and lesions. For example, a July 2024 report by the UK Health Security Agency highlighted that England recorded 401,800 new STI diagnoses in 2023, a 4.7% increase from 2022. Gonorrhea cases rose by 7.5%, from 79,268 to 85,223, while syphilis diagnoses increased by 9.4%, from 8,693 to 9,513. These rising infection rates underscore the growing need for effective contraceptive devices in the market.

Breakdown of the Contraceptive Devices Market by Product Types and Technologies

This market is segmented across various dimensions to capture the diverse range of products and technologies available. By product type, the categories include Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms and Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, and other types. When considering technology, the market is divided into Hormonal Contraceptives and Barrier Contraceptives. Distribution channels encompass Hospital Pharmacies, Retail Pharmacies, Clinics, Online Platforms, Public Channels and NGOs, and other pathways. Further subsegment details include male condoms, vasectomy devices, injections, and pills within the male devices category; female condoms and various vaginal barrier methods under female devices; and various types of IUDs and implants broken down by their hormonal and non-hormonal nature.

Access The Complete Contraceptive Devices Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Innovations in Contraceptive Devices Highlighted by Market Trends

Leading firms in the contraceptive devices space are continually innovating to meet consumer needs for convenience and efficacy. A prime example is the contraceptive vaginal ring, a flexible, hormone-releasing device designed for monthly insertion that prevents pregnancy by releasing hormones to inhibit ovulation and thicken cervical mucus. In October 2023, US-based pharmaceutical company Xiromed LLC introduced the EnilloRing, a vaginal ring combining etonogestrel and ethinyl estradiol. This device is intended for long-term use, staying in place for three weeks followed by a one-week break, offering an easy-to-use birth control solution that aligns with modern lifestyles.

Key Players Driving Competition and Development in the Contraceptive Devices Market

The competitive landscape of the contraceptive devices market features several major companies that shape industry trends and product availability. These include Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, and Pregna International Limited, among others. Their ongoing research and development efforts continue to introduce new contraceptive options and improve existing ones.

Regional Market Distribution and Growth Patterns in the Contraceptive Devices Sector

Geographically, North America held the largest share of the contraceptive devices market in 2025. Meanwhile, Asia-Pacific is forecasted to be the fastest-growing region throughout the projection period. The report covers multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global overview of market expansion and regional opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model